NCT03474718Early phase 1Not yet recruiting
Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Early phase 1
- Sponsor
- Wake Forest University Health Sciences
- Participants (registry)
- 16
- Start
- October 2026 (planned)
- Primary completion
- July 2027 (planned)
- Study completion
- July 2027 (planned)
- Last registry update
- August 2026
- Countries
- United States
Conditions studied: Androgenic Alopecia
Interventions: Platelet-rich Plasma Left Side, Platelet-rich Plasma Right Side
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.